Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

SD Biotechnologies Co stock price, quote, forecast and news

217480.KQ
KR7217480003

Price

500.14 KRW
Today +/-
+0 KRW
Today %
+0 %
P

SD Biotechnologies Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into SD Biotechnologies Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by SD Biotechnologies Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects SD Biotechnologies Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of SD Biotechnologies Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into SD Biotechnologies Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing SD Biotechnologies Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on SD Biotechnologies Co’s growth potential.

SD Biotechnologies Co Revenue, EBIT and net profit per share

DateSD Biotechnologies Co RevenueSD Biotechnologies Co EBITSD Biotechnologies Co Net Income
202346.94 B KRW-13.66 B KRW-4.61 B KRW
202256.57 B KRW-31.52 B KRW-72.75 B KRW
2021124.68 B KRW-34.82 B KRW-43.57 B KRW
2020140.73 B KRW-3.71 B KRW-8.67 B KRW
2019156.26 B KRW-16.41 B KRW-18.45 B KRW
2018156.62 B KRW10.35 B KRW8.97 B KRW
2017127.4 B KRW19.44 B KRW14.14 B KRW
2016104.69 B KRW28.08 B KRW22.46 B KRW
201574.63 B KRW26.52 B KRW18.29 B KRW
20149.7 B KRW3.07 B KRW2.59 B KRW
20131.04 B KRW1 M KRW-29 M KRW

SD Biotechnologies Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B KRW)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B KRW)EBIT (B KRW)EBIT MARGIN (%)NET INCOME (B KRW)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20132014201520162017201820192020202120222023
1.049.774.63104.69127.4156.62156.26140.73124.6856.5746.94
-835.81669.8240.2721.6922.94-0.23-9.94-11.40-54.63-17.02
51.3540.7259.0562.4554.4348.4632.4636.6429.0332.4542.17
0.533.9544.0765.3869.3475.950.7151.5636.218.3619.8
03.0726.5228.0819.4410.35-16.41-3.71-34.82-31.52-13.66
0.1031.6335.5326.8215.266.60-10.50-2.64-27.93-55.72-29.09
-0.032.5918.2922.4614.148.97-18.45-8.67-43.57-72.75-4.61
--9,024.14606.6122.82-37.04-36.57-305.63-53.01402.6166.99-93.67
161618192222222217.6318.3832.12
-----------
Details

Keystats

ⓘ

Revenue and Growth

The SD Biotechnologies Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the SD Biotechnologies Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M KRW)RECEIVABLES (M KRW)OTHER REC. (M KRW)INVENTORIES (M KRW)OTHER CURRENT LIAB. (M KRW)CURRENT ASSETS (M KRW)TANGIBLE ASSETS (M KRW)LONG-T. INVEST. (M KRW)LONG-T. REC. (M KRW)INTANGIBLE ASSETS (M KRW)GOODWILL (M KRW)OTHER NON-CURRENT ASSETS (M KRW)NON-CURRENT ASSETS (M KRW)TOTAL ASSETS (M KRW)LIABILITIESCOMMON STOCK (M KRW)ADDITIONAL PAID-IN CAPITAL (M KRW)RETAINED EARNINGS (M KRW)OTHER EQUITY (M KRW)UNREAL. GAINS/LOSSES (M KRW)EQUITY (M KRW)LIABILITIES (M KRW)PROVISIONS (M KRW)OTHER SHORT-TERM LIAB. (M KRW)SHORT-TERM DEBTS (M KRW)LONG-TERM DEBT PORTION (M KRW)SHORT-TERM REC. (M KRW)LONG-T. LIAB. (M KRW)DEFERRED TAXES (M KRW)OTHER LIAB. (M KRW)LONG-T. LIABILITIES (M KRW)DEBT (M KRW)TOTAL CAPITAL (M KRW)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of SD Biotechnologies Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand SD Biotechnologies Co's financial health and stability.

Assets

SD Biotechnologies Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that SD Biotechnologies Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of SD Biotechnologies Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into SD Biotechnologies Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B KRW)DEPRECIATION (B KRW)DEFERRED TAXES (M KRW)CHANGES IN WORKING CAPITAL (B KRW)NON-CASH ITEM (B KRW)PAID INTEREST (B KRW)PAID TAXES (B KRW)NET CASH FLOW FROM OPERATING ACTIVITIES (B KRW)CAPITAL EXPENDITURES (M KRW)CASH FLOW FROM INVESTING ACTIVITIES (B KRW)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B KRW)INTEREST INCOME AND EXPENSES (M KRW)NET DEBT CHANGE (B KRW)NET CHANGE IN EQUITY (B KRW)CASH FLOW FROM FINANCING ACTIVITIES (B KRW)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M KRW)TOTAL DIVIDENDS PAID (M KRW)NET CHANGE IN CASH FLOW (B KRW)FREE CASH FLOW (M KRW)SHARE-BASED COMPENSATION (M KRW)
2013201420152016201720182019202020212022
02.5918.2922.4513.468.45-22.02-9.77-45.15-52.01
00.020.210.571.362.042.373.423.945.53
0000000000
-0.25-0.95-7.67-16.9-28.57-32.752.332.998.1212.92
00.5111.357.346.662.3624.06-1.2215.7811.03
00.030.010.020.230.390.560.8211.92
0.020.060.79.056.284.891.061.162.96-0.01
-0.252.1722.1813.46-7.09-19.96.74-4.58-17.31-22.54
-7-242-12,382-6,179-20,007-6,782-12,255-4,286-16,322-24,260
-0.03-0.34-22.34-9.89-34.442.16-7.53-9.71-1.96-1.6
-0.02-0.1-9.96-3.71-14.448.944.72-5.4314.3622.66
0000000000
0.08-0.191.8-0.73-0.9919.370.4316.7520.373.67
0.206.981.0837.053.0800033.84
0.27-0.198.680.8636.1819.140.6316.7519.9516.86
01-9850911202000-419-20,650
00000-3,3100000
01.648.564.26-5.751.310.12.522.48-7.11
-2561,9309,7967,277-27,099-26,681-5,517-8,866-33,634.2-46,795.44
0000000000

SD Biotechnologies Co stock margins

The SD Biotechnologies Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of SD Biotechnologies Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for SD Biotechnologies Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the SD Biotechnologies Co's sales revenue. A higher gross margin percentage indicates that the SD Biotechnologies Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the SD Biotechnologies Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the SD Biotechnologies Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the SD Biotechnologies Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the SD Biotechnologies Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the SD Biotechnologies Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

SD Biotechnologies Co Margin History

SD Biotechnologies Co Gross marginSD Biotechnologies Co Profit marginSD Biotechnologies Co EBIT marginSD Biotechnologies Co Profit margin
202342.17 %-29.09 %-9.82 %
202232.45 %-55.72 %-128.59 %
202129.04 %-27.93 %-34.94 %
202036.64 %-2.64 %-6.16 %
201932.46 %-10.5 %-11.8 %
201848.46 %6.6 %5.73 %
201754.43 %15.26 %11.1 %
201662.45 %26.82 %21.45 %
201559.05 %35.53 %24.5 %
201440.72 %31.63 %26.69 %
201351.35 %0.1 %-2.8 %

SD Biotechnologies Co Stock Sales Revenue, EBIT, Earnings per Share

The SD Biotechnologies Co earnings per share therefore indicates how much revenue SD Biotechnologies Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue SD Biotechnologies Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates SD Biotechnologies Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of SD Biotechnologies Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating SD Biotechnologies Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

SD Biotechnologies Co Revenue, EBIT and net profit per share

DateSD Biotechnologies Co Sales per ShareSD Biotechnologies Co EBIT per shareSD Biotechnologies Co Earnings per Share
20231,461.41 KRW-425.12 KRW-143.47 KRW
20223,077.22 KRW-1,714.7 KRW-3,957.06 KRW
20217,070.49 KRW-1,974.73 KRW-2,470.61 KRW
20206,396.59 KRW-168.73 KRW-394 KRW
20197,102.68 KRW-745.77 KRW-838.41 KRW
20187,119.27 KRW470.23 KRW407.73 KRW
20175,791 KRW883.5 KRW642.77 KRW
20165,510.11 KRW1,477.95 KRW1,182.11 KRW
20154,146.33 KRW1,473.11 KRW1,015.94 KRW
2014605.94 KRW191.69 KRW161.75 KRW
201364.75 KRW0.06 KRW-1.81 KRW

SD Biotechnologies Co business model

SD Biotechnologies Co is one of the most popular companies on Eulerpool.com.

SD Biotechnologies Co historical P/E ratio, EBIT, and P/S ratio.

SD Biotechnologies Co shares outstanding

The number of shares was SD Biotechnologies Co in 2023 — This indicates how many shares 32.122 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue SD Biotechnologies Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates SD Biotechnologies Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of SD Biotechnologies Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating SD Biotechnologies Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

SD Biotechnologies Co Stock splits

In SD Biotechnologies Co's history, there have been no stock splits.

SD Biotechnologies Co dividend history and estimates

In 2023, SD Biotechnologies Co paid a dividend amounting to 0 KRW. Dividend means that SD Biotechnologies Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for SD Biotechnologies Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify SD Biotechnologies Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating SD Biotechnologies Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

SD Biotechnologies Co Dividend History

DateSD Biotechnologies Co Dividend
2017126.94 KRW

SD Biotechnologies Co dividend payout ratio

In 2023, SD Biotechnologies Co had a payout ratio of 19.75%. The payout ratio indicates the percentage of the company's profits that SD Biotechnologies Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for SD Biotechnologies Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for SD Biotechnologies Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate SD Biotechnologies Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

SD Biotechnologies Co Payout Ratio History

DateSD Biotechnologies Co Payout ratio
202319.75 %
202219.75 %
202119.75 %
202019.75 %
201919.75 %
201819.75 %
201719.75 %
201619.75 %
201519.75 %
201419.75 %
201319.75 %
Unfortunately, there are currently no price targets and forecasts available for SD Biotechnologies Co.

SD Biotechnologies Co list of shareholders

%
Name
Stocks
Change
Date
4.02 % Park (Seol Ung)4,405,78209/30/2023
0.02 % Soye Co Ltd25,79309/30/2023
1

SD Biotechnologies Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Genic Stock
Genic
SupplierCustomer0,890,910,490,440,80-0,35
Sa Sa International Holdings Stock
Sa Sa International Holdings
SupplierCustomer0,460,560,150,330,79-0,17
1

Most common questions regarding SD Biotechnologies Co

What is the P/E ratio of SD Biotechnologies Co 2024?

The P/E ratio cannot be calculated for SD Biotechnologies Co at the moment.

What is the P/S ratio of SD Biotechnologies Co 2024?

The P/S cannot be calculated for SD Biotechnologies Co currently.

What is the AlleAktien quality score of SD Biotechnologies Co?

The AlleAktien quality score for SD Biotechnologies Co is 4/10.

What is the revenue of SD Biotechnologies Co 2024?

The revenue cannot currently be calculated for SD Biotechnologies Co.

How high is the profit of SD Biotechnologies Co 2024?

The profit cannot currently be calculated for SD Biotechnologies Co.

What is the business model of SD Biotechnologies Co

No history available for SD Biotechnologies Co.

What is the SD Biotechnologies Co dividend?

SD Biotechnologies Co pays a dividend of 0 KRW distributed over payouts per year.

How often does SD Biotechnologies Co pay dividends?

The dividend cannot currently be calculated for SD Biotechnologies Co or the company does not pay out a dividend.

What is the SD Biotechnologies Co ISIN?

The ISIN of SD Biotechnologies Co is KR7217480003.

What is the SD Biotechnologies Co ticker?

The ticker of SD Biotechnologies Co is 217480.KQ.

How much dividend does SD Biotechnologies Co pay?

Over the past 12 months, SD Biotechnologies Co paid a dividend of 126.94 KRW . This corresponds to a dividend yield of about 25.38 %. For the coming 12 months, SD Biotechnologies Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of SD Biotechnologies Co?

The current dividend yield of SD Biotechnologies Co is 25.38 %.

When does SD Biotechnologies Co pay dividends?

SD Biotechnologies Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SD Biotechnologies Co?

SD Biotechnologies Co paid dividends every year for the past 0 years.

What is the dividend of SD Biotechnologies Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is SD Biotechnologies Co located?

SD Biotechnologies Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von SD Biotechnologies Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SD Biotechnologies Co from 4/13/2018 amounting to 150 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2017.

When did SD Biotechnologies Co pay the last dividend?

The last dividend was paid out on 4/13/2018.

What was the dividend of SD Biotechnologies Co in the year 2023?

In the year 2023, SD Biotechnologies Co distributed 0 KRW as dividends.

In which currency does SD Biotechnologies Co pay out the dividend?

The dividends of SD Biotechnologies Co are distributed in KRW.

All fundamentals about SD Biotechnologies Co

Our stock analysis for SD Biotechnologies Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SD Biotechnologies Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.